Spots Global Cancer Trial Database for Adherence to Oral Therapies in Advanced Breast and Prostate Cancers
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adherence to Oral Therapies in Advanced Breast and Prostate Cancers
Official Title: Adherence to Oral Therapies in Advanced Breast and Prostate Cancers: a Pilot Study
Study ID: NCT06435546
Study Description
Brief Summary: AdOTAC is a pilot study, open, prospective, single-center, one-arm. The 200 patients will be included. Patient is included at Day 0. The included patient will have the opportunity to complete the self-questionnaires either at the ICL on Day 0, or at home up to 10 days after the date of inclusion in the study. Blood samples are collected the day of enrolment (Day 0) in order to measure the following biological markers: ferritin, serum iron, TSAT, albumin, and haemoglobin, except if performed as part of routine care in the previous 6 weeks.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, , France
Contact Details
Name: Vincent Massard, MD
Affiliation: Institut de Cancérologie de Lorraine
Role: PRINCIPAL_INVESTIGATOR
Name: Naoual Boujedaini, PhD
Affiliation: Institut de Cancérologie de Lorraine
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
